Nationwide outcomes of cardiac surgery in patients with cannabis use disorder

J Cardiothorac Surg. 2026 Jan 17. doi: 10.1186/s13019-025-03755-6. Online ahead of print.ABSTRACTOBJECTIVE: To characterize in-hospital morbidity and mortality in patients undergoing cardiovascular surgery with and without cannabis use disorder (CUD) using a national database.METHODS: Between 2016 a

K Krish C Dewan

SGLT-2 inhibitors and GLP-1 receptor agonists in primary care pharmacotherapy of type 2 diabetes in people living with HIV versus HIV-negative controls: Findings from a multicenter study in Germany

Prim Care Diabetes. 2026 Jan 16:S1751-9918(26)00005-7. doi: 10.1016/j.pcd.2026.01.005. Online ahead of print.ABSTRACTAIMS: Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) improve glycemic control and reduce cardiovascular (CV) mortality. H

L L Hilgefort

Sleep apnoea and its consequences: from animal models to precision medicine

Sleep Med. 2026 Jan 8;140:108777. doi: 10.1016/j.sleep.2026.108777. Online ahead of print.ABSTRACTA European Respiratory Society research seminar entitled "Sleep Apnoea and Its Consequences: From Animal Models to Precision Medicine" was held in January 2024 in Lisbon, Portugal. It provided an in-dep

R Raphael Heinzer